Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages

Objective: The objective of this study was to investigate the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on renal function in different stages of chronic kidney disease (CKD). Design and Methods: We conducted a retrospective cohort study using longitudinal claims data from May 2016...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Hsuan, Huang, Yu-Yao, Hsieh, Sheng-Hwu, Sun, Jui-Hung, Chen, Szu-Tah, Lin, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883723/
https://www.ncbi.nlm.nih.gov/pubmed/31824432
http://dx.doi.org/10.3389/fendo.2019.00820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883723/
https://www.ncbi.nlm.nih.gov/pubmed/31824432
http://dx.doi.org/10.3389/fendo.2019.00820

Ejemplares similares